Details
Stereochemistry | RACEMIC |
Molecular Formula | C22H28NO3.CH3O4S |
Molecular Weight | 465.56 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COS([O-])(=O)=O.C[N+]1(C)CCCCC1COC(=O)C(O)(C2=CC=CC=C2)C3=CC=CC=C3
InChI
InChIKey=AXKJGGRSAVLXTE-UHFFFAOYSA-M
InChI=1S/C22H28NO3.CH4O4S/c1-23(2)16-10-9-15-20(23)17-26-21(24)22(25,18-11-5-3-6-12-18)19-13-7-4-8-14-19;1-5-6(2,3)4/h3-8,11-14,20,25H,9-10,15-17H2,1-2H3;1H3,(H,2,3,4)/q+1;/p-1
Molecular Formula | CH3O4S |
Molecular Weight | 111.097 |
Charge | -1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C22H28NO3 |
Molecular Weight | 354.4626 |
Charge | 1 |
Count |
|
Stereochemistry | MIXED |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2094109 Sources: http://www.genome.jp/dbget-bin/www_bget?dr:D01532 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sources: http://infomeds.net/akabel.html |
Primary | ACABEL Approved UseAcabel (Bevonium methyl sulfate) is parasympatolytic drug with well balanced action on the neuromuscular device. Possesses broncho-and spasmolytic properties. Acabel is indicated for bronchial asthma, peptic ulcer of a stomach and duodenum, pylorospasm, postoperative spastic pains, spastic locks, cholestasia, cholecystitis, cholangitis, postcholecystectomy syndrome, chronic hepatopathy and pancreatitis, various diseases of kidneys and urinary tract. Prenatal and puerperal pains, dysmenorrhea, adnexitis, endometritis, dysfunction of ovaries, tumor of genitalias. |
PubMed
Title | Date | PubMed |
---|---|---|
[Effect of piribenzil methylsulfate (CG-201) on ureteral activity]. | 1968 Nov |
|
[Bevonium methylsulfate (CG 201) in the treatment of enuresis and bladder neurosis]. | 1970 Jul |
|
Letter: A double-blind trial of bevonium methylsulphate on gastric acid secretion in man. | 1976 Jan 3 |
Patents
Sample Use Guides
Form of release of medicine: Acabel: tablets on 50 mg, candles on 30 pieces in packaging. Acabel compositum: tablets (bevonium methyl sulfate — 0,05 g, Dipyronum — 0,25 g); candles (bevonium methyl sulfate — 0,03 g, Dipyronum — 1 g); ampoules on 5 ml (bevonium methyl sulfate — 0,0025 g, Dipyronum — 2,5 g).
Use: Acabel appoint inside 1 — 2 tablet 2 — 3 times a day, candles (only the adult) — on 1 piece 2 — 3 times a day. Intramusculary or intravenously slowly enter on 1/2 — 1 ampoule of an akabel difficult 3 once a day.
Route of Administration:
Other
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:36:47 GMT 2023
by
admin
on
Fri Dec 15 15:36:47 GMT 2023
|
Record UNII |
UWC15E373Z
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C66880
Created by
admin on Fri Dec 15 15:36:47 GMT 2023 , Edited by admin on Fri Dec 15 15:36:47 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
31799
Created by
admin on Fri Dec 15 15:36:47 GMT 2023 , Edited by admin on Fri Dec 15 15:36:47 GMT 2023
|
PRIMARY | |||
|
C72944
Created by
admin on Fri Dec 15 15:36:47 GMT 2023 , Edited by admin on Fri Dec 15 15:36:47 GMT 2023
|
PRIMARY | |||
|
SUB05809MIG
Created by
admin on Fri Dec 15 15:36:47 GMT 2023 , Edited by admin on Fri Dec 15 15:36:47 GMT 2023
|
PRIMARY | |||
|
CHEMBL1882461
Created by
admin on Fri Dec 15 15:36:47 GMT 2023 , Edited by admin on Fri Dec 15 15:36:47 GMT 2023
|
PRIMARY | |||
|
226-001-8
Created by
admin on Fri Dec 15 15:36:47 GMT 2023 , Edited by admin on Fri Dec 15 15:36:47 GMT 2023
|
PRIMARY | |||
|
5205-82-3
Created by
admin on Fri Dec 15 15:36:47 GMT 2023 , Edited by admin on Fri Dec 15 15:36:47 GMT 2023
|
PRIMARY | |||
|
DTXSID3046615
Created by
admin on Fri Dec 15 15:36:47 GMT 2023 , Edited by admin on Fri Dec 15 15:36:47 GMT 2023
|
PRIMARY | |||
|
UWC15E373Z
Created by
admin on Fri Dec 15 15:36:47 GMT 2023 , Edited by admin on Fri Dec 15 15:36:47 GMT 2023
|
PRIMARY | |||
|
m2467
Created by
admin on Fri Dec 15 15:36:47 GMT 2023 , Edited by admin on Fri Dec 15 15:36:47 GMT 2023
|
PRIMARY | Merck Index | ||
|
100000085874
Created by
admin on Fri Dec 15 15:36:47 GMT 2023 , Edited by admin on Fri Dec 15 15:36:47 GMT 2023
|
PRIMARY | |||
|
2456
Created by
admin on Fri Dec 15 15:36:47 GMT 2023 , Edited by admin on Fri Dec 15 15:36:47 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE | |||
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |